UroGen Pharma
URGN
9,30 €
Share price
-2.66%
Change (1 day)
-23.62%
Change (1 year)
Categories
Revenue for UroGen Pharma (URGN)
Revenue in 2024 (TTM): €83.94 Million
According to UroGen Pharma's latest financial reports the company's current revenue (TTM 
) is €82.02 Million. an increase over the revenue in the year 2023 that were of €74.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for UroGen Pharma from 2017 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | €86.86 M | 16.1% |
| 2023 | €74.82 M | 24.71% |
| 2022 | €59.99 M | 41.43% |
| 2021 | €42.42 M | 342.22% |
| 2020 | €9.59 M | 59600.56% |
| 2019 | €0.01 M | -98.37% |
| 2018 | €0.98 M | -85.5% |
| 2017 | €6.79 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |